Article content
UC San Diego Health implants the world's first dual-chamber and leadless pacemaker system to help treat people with irregular heart rhythms known as arrhythmias, which can lead to complications such as palpitations, fainting, and stroke It is the first health care system in San Diego to succeed.
The Centers for Disease Control and Prevention estimates that atrial fibrillation, the most common arrhythmia, is expected to affect approximately 12.1 million people in the United States by 2030. Pacemakers and implantable cardioverter defibrillators (ICDs) are standard treatments for regulating irregular heartbeats in patients.
A new leadless pacemaker system placed in both chambers of the heart and using new communication technology, approved by the U.S. Food and Drug Administration (FDA) in July 2023, could offer a less invasive option for patients. became.
UC San Diego implanted its first patient with a pacemaker system in February 2024.
“Having the option to use a leadless pacemaker system on both sides of the heart would allow us to treat more people who currently have cardiac arrhythmias,” said Dr. McConlogue, a cardiologist and director of pacemaker and ICD services at the University of California, Sun. said Dr. Ulrika Birgersdotter-Green, the person in charge. Diego Health.
Almost 80% of patients with pacemakers require a dual chamber option. Leadless pacemakers are a preferred option for patients, but historically they were only available to people who needed pacing on one side of the heart.
